The Czech Republic stands as a central hub for medical excellence and biotechnological innovation in Central Europe. With a robust healthcare system supported by the State Institute for Drug Control (SÚKL), the demand for high-precision Infectious Disease Diagnostic Systems has seen an unprecedented rise. As a specialized manufacturer serving the Czech market, we understand the critical balance between innovation and compliance.
The Czech Republic's industrial status is characterized by a sophisticated network of public hospitals (e.g., FN Motol, VFN Prague) and private diagnostic clusters. There is a growing emphasis on decentralizing testing—moving from centralized laboratory hubs to Point-of-Care Testing (POCT) in regional clinics and veterinary practices. This shift requires diagnostic systems that are not only accurate but also portable and easy to operate without extensive specialized training.
The Czech IVD (In Vitro Diagnostics) market is currently undergoing a digital transformation. Integration with national health databases and the adoption of AI-driven analysis are the primary drivers. Our manufacturing approach prioritizes "Information Gain," providing Czech clinicians with data that goes beyond a simple "positive/negative" result, offering semi-quantitative insights and viral load tracking.
Globally, the molecular diagnostic market is pivoting toward multiplexing—the ability to detect multiple pathogens from a single sample. In the Czech Republic, this is particularly relevant for respiratory panel testing and tick-borne diseases, given the geographical prevalence of Lyme Borreliosis and Tick-borne Encephalitis in the Bohemian and Moravian regions.
Diagnostic Accuracy
Average Rapid Test Time
Compliant Standards
Any manufacturer serving the Czech Republic must strictly adhere to the European Union's In Vitro Diagnostic Regulation (IVDR 2017/746). Our factory ensures that all systems—whether for human clinical use or veterinary applications—meet these stringent safety and performance requirements. We provide full technical documentation in English and Czech to facilitate seamless registration with local authorities.
Our Infectious Disease Diagnostic Systems are tailored for three primary sectors in the Czech Republic:
We are moving beyond traditional lateral flow assays into the realm of Microfluidic Lab-on-a-Chip technology. For the Czech market, our R&D is focused on:
Our factory, Shenzhen BioX Medical Co., Ltd., integrates these innovations into every unit shipped to Central Europe, ensuring that Czech laboratories remain at the global forefront of diagnostic precision.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
BioX Medical
